As a geneticist. I spend a lot of time looking at genomes. But until I taught my “Genetics and Society” class at Berkeley last year, I had never looked at my own DNA sequence. What better way to teach genetics than to use my genome as an example of what can and can’t be learned? So I sent $99 and a vial of spit to 23andMe, the now beleaguered “direct to consumer” genomics service.
Last week, 23andMe stopped providing health-related genome interpretations to new customers.
Sadly, the company’s woes play to those who argue that personal genetic information is too complicated for lay people to understand and should only be delivered by medical professionals.
Read the full, original story: Risky Business: 23andMe And The FDA